BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
Advances progress towards planned Nasdaq uplisting PR Audio: POMPANO BEACH, Fla., July 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the filing […]
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
POMPANO BEACH, Fla., June 10, 2026 — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Planet MicroCap Las Vegas 2026 Conference. BioStem is scheduled to present on Wednesday, June 17, 2026, at […]
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
The new independent directors strengthen the Company’s board as seasoned executives bring deep expertise in life sciences commercialization, healthcare administration, and investment management PR Audio: POMPANO BEACH, Fla., June 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the […]
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
Strengthening balance sheet on path to Nasdaq uplisting POMPANO BEACH, Fla., May 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a securities […]
BioStem Technologies Reports First Quarter 2026 Financial Results
POMPANO BEACH, Fla., May 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026. Recent Financial and Business Highlights “The […]
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
POMPANO BEACH, Fla., May 12, 2026 PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 16th Annual LD Micro Invitational in Los Angeles, CA. BioStem’s management […]